Skip to main content
Clinical Trials/JPRN-UMIN000039249
JPRN-UMIN000039249
Completed
未知

A study on the effects of application of compounded stenone cream (fermented product enriched with plant stenones) on subcutaneous fat and visceral fat. - A study on the effects of application of compounded stenone cream (fermented product enriched with plant stenones) on subcutaneous fat and visceral fat.

imeQ RD inc.0 sites30 target enrollmentJanuary 24, 2020
ConditionsHealthy adults

Overview

Phase
未知
Intervention
Not specified
Conditions
Healthy adults
Sponsor
imeQ RD inc.
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 24, 2020
End Date
April 26, 2020
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
imeQ RD inc.

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Those are currently receiving some types of drug treatment (e.g. treatment affecting obesity, hyperlipidemia, and lipid metabolism). 2\. Those who are receiving nutrition therapy or physical therapy under a doctor's supervision. 3\. Those who cannot stop taking health foods or supplements (those which may affect obesity, hyperlipidemia, and lipid metabolism) during the study period. 4\. Those who cannot stop drinking alcohol the day before a test. 5\. Those who have a current or a past medical history of severe diseases. 6\. Those who have skin diseases (e.g. atopic dermatitis) or a hypersensitivity. 7\. Those who have a current or a past medical history of drug or food allergy. 8\. Those who have a current or a past medical history of drug or alcohol dependence. 9\. Those who have metals implanted in the body due to surgery etc. 10\. Those who have a cardiac pacemaker or an implantable medical device placed in the body. 11\. Those who have claustrophobia. 12\. Those who work night shifts. 13\. Smokers. 14\. Those who are currently pregnant or breastfeeding or those who want to become pregnant during the study period. 15\. Those who are currently participating in another clinical trial or those who took a test product and completed another clinical trial in a month. 16\. Those who were determined by the principal investigator or a sub\-investigator to be an unsuitable subject for this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials